Cargando…

An Update on Treatment of Drug-Induced Liver Injury

Drug-induced liver injury (DILI) has been linked to more than 1,000 medications and remains the most common cause of acute liver failure in the United States. Here, we review the most current literature regarding treatment and make recommendations for the management of this relatively common disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Giordano, Christin, Rivas, John, Zervos, Xaralambos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521262/
https://www.ncbi.nlm.nih.gov/pubmed/26356645
http://dx.doi.org/10.14218/JCTH.2014.00005
_version_ 1782383783083769856
author Giordano, Christin
Rivas, John
Zervos, Xaralambos
author_facet Giordano, Christin
Rivas, John
Zervos, Xaralambos
author_sort Giordano, Christin
collection PubMed
description Drug-induced liver injury (DILI) has been linked to more than 1,000 medications and remains the most common cause of acute liver failure in the United States. Here, we review the most current literature regarding treatment and make recommendations for the management of this relatively common disease. Since treatment of DILI remains largely elusive, recent studies have attempted to define new management strategies for these difficult patients. Early diagnosis and withdrawal of the suspected medication is the mainstay of treatment of DILI. For acetaminophen and Amanita mushroom poisoning, there are specific therapies in use. Finally, there are other possible management modalities for DILI, including corticosteroids and ursodeoxycholic acid.
format Online
Article
Text
id pubmed-4521262
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher XIA & HE Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-45212622015-09-09 An Update on Treatment of Drug-Induced Liver Injury Giordano, Christin Rivas, John Zervos, Xaralambos J Clin Transl Hepatol Review Article Drug-induced liver injury (DILI) has been linked to more than 1,000 medications and remains the most common cause of acute liver failure in the United States. Here, we review the most current literature regarding treatment and make recommendations for the management of this relatively common disease. Since treatment of DILI remains largely elusive, recent studies have attempted to define new management strategies for these difficult patients. Early diagnosis and withdrawal of the suspected medication is the mainstay of treatment of DILI. For acetaminophen and Amanita mushroom poisoning, there are specific therapies in use. Finally, there are other possible management modalities for DILI, including corticosteroids and ursodeoxycholic acid. XIA & HE Publishing Ltd 2014-06-15 2014-06 /pmc/articles/PMC4521262/ /pubmed/26356645 http://dx.doi.org/10.14218/JCTH.2014.00005 Text en © 2014 The Second Affiliated Hospital of Chongqing Medical University. Published by XIA & HE Publishing Ltd. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 4.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Giordano, Christin
Rivas, John
Zervos, Xaralambos
An Update on Treatment of Drug-Induced Liver Injury
title An Update on Treatment of Drug-Induced Liver Injury
title_full An Update on Treatment of Drug-Induced Liver Injury
title_fullStr An Update on Treatment of Drug-Induced Liver Injury
title_full_unstemmed An Update on Treatment of Drug-Induced Liver Injury
title_short An Update on Treatment of Drug-Induced Liver Injury
title_sort update on treatment of drug-induced liver injury
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521262/
https://www.ncbi.nlm.nih.gov/pubmed/26356645
http://dx.doi.org/10.14218/JCTH.2014.00005
work_keys_str_mv AT giordanochristin anupdateontreatmentofdruginducedliverinjury
AT rivasjohn anupdateontreatmentofdruginducedliverinjury
AT zervosxaralambos anupdateontreatmentofdruginducedliverinjury
AT giordanochristin updateontreatmentofdruginducedliverinjury
AT rivasjohn updateontreatmentofdruginducedliverinjury
AT zervosxaralambos updateontreatmentofdruginducedliverinjury